BR0114632A - Compostos aminotriazolonas, o respectivo processo de preparo e as composições farmacêuticas que os contêm - Google Patents
Compostos aminotriazolonas, o respectivo processo de preparo e as composições farmacêuticas que os contêmInfo
- Publication number
- BR0114632A BR0114632A BR0114632-7A BR0114632A BR0114632A BR 0114632 A BR0114632 A BR 0114632A BR 0114632 A BR0114632 A BR 0114632A BR 0114632 A BR0114632 A BR 0114632A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- pharmaceutical compositions
- preparation process
- compositions containing
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMPOSTOS AMINOTRIAZOLONAS, O RESPECTIVO PROCESSO DE PREPARO E AS COMPOSIçõES FARMACêUTICAS QUE OS CONTêM". A presente invenção refere-se a um composto de fórmula (I), no qual R~ 3~ representa um átomo de hidrogênio ou um grupamento alquila, alquenila, alquinila, arila, heteroarila, cicloalquila ou heterocicloalquila; R~ 4~ representa um grupamento de fórmula (II), na qual B representa um grupamento mono ou policíclico, aromático ou não, contendo de 3 a 10 membros, podendo conter de 1 a 3 heteroátomos; R~ 5~ representa um átomo de hidrogênio ou um grupamento alquila, A representa um grupamento escolhido dentre -A~ 2~-, -A~ 1~-A~ 2~-, -A~ 2-A~ 1~- ou com -A~ 1~-,-A~ 2~-,-A~ 1~-; V representa uma ligação ou um grupamento -CH~ 2~-, -CO-, -CS-, CH~ 2~-NH- ou -CH=N-, ou V e R~ 3~ formam juntos com os grupamentos -A- e -N-R~ 4~ que os portam um grupamento -A-CH=N-R~ 4~, e sua utilização no tratamento das patologias ligadas ao neuropeptídeo Y (NPY).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0013125A FR2815346B1 (fr) | 2000-10-13 | 2000-10-13 | Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2001/003133 WO2002030923A1 (fr) | 2000-10-13 | 2001-10-11 | Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0114632A true BR0114632A (pt) | 2004-02-17 |
Family
ID=8855314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0114632-7A BR0114632A (pt) | 2000-10-13 | 2001-10-11 | Compostos aminotriazolonas, o respectivo processo de preparo e as composições farmacêuticas que os contêm |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040029875A1 (pt) |
EP (1) | EP1324998A1 (pt) |
JP (1) | JP2004515475A (pt) |
KR (1) | KR20030036929A (pt) |
CN (1) | CN1468233A (pt) |
AR (1) | AR031726A1 (pt) |
AU (1) | AU2002210632A1 (pt) |
BR (1) | BR0114632A (pt) |
CA (1) | CA2424802A1 (pt) |
CZ (1) | CZ20031290A3 (pt) |
EA (1) | EA200300458A1 (pt) |
FR (1) | FR2815346B1 (pt) |
HU (1) | HUP0302408A2 (pt) |
MX (1) | MXPA03002956A (pt) |
NO (1) | NO20031643D0 (pt) |
PL (1) | PL360090A1 (pt) |
SK (1) | SK5712003A3 (pt) |
WO (1) | WO2002030923A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101674801A (zh) * | 2007-01-31 | 2010-03-17 | 西巴控股公司 | 阳离子染料 |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
KR101897881B1 (ko) | 2008-01-04 | 2018-09-12 | 인텔리카인, 엘엘씨 | 특정 화학 물질, 조성물 및 방법 |
KR100971811B1 (ko) * | 2008-03-27 | 2010-07-22 | 엘에스전선 주식회사 | 커넥터가 구비된 광복합 전력케이블 접속함 |
US8809349B2 (en) | 2011-01-10 | 2014-08-19 | Infinity Pharmaceuticals, Inc. | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
US10046974B2 (en) | 2013-02-05 | 2018-08-14 | Basf Se | Process for preparing a boron containing zeolitic material having MWW framework structure |
WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
CA3028718A1 (en) | 2016-06-24 | 2017-12-28 | Infinity Pharmaceuticals, Inc. | Combination therapies |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2435521C3 (de) * | 1974-07-24 | 1982-01-21 | L. & C. Steinmüller GmbH, 5270 Gummersbach | Selbsttragendes Beton-Stahl-Verbundelement zur Auskleidung von Behältern |
PT76280A (en) * | 1982-02-24 | 1983-03-01 | Glaxo Group Ltd | Process for preparing heterocyclic derivatives |
GB2236339B (en) * | 1989-09-07 | 1994-06-01 | Kajima Corp | Trusses and precast concrete slabs reinforced thereby |
DE4326465A1 (de) * | 1993-01-20 | 1995-02-09 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
AU7738198A (en) * | 1996-12-15 | 1998-07-15 | Banyu Pharmaceutical Co., Ltd. | Aminopyrazole derivatives |
PE20000127A1 (es) * | 1997-12-22 | 2000-03-14 | Novartis Ag | Derivado de bencenosulfonamida |
-
2000
- 2000-10-13 FR FR0013125A patent/FR2815346B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-11 CA CA002424802A patent/CA2424802A1/fr not_active Abandoned
- 2001-10-11 AU AU2002210632A patent/AU2002210632A1/en not_active Abandoned
- 2001-10-11 HU HU0302408A patent/HUP0302408A2/hu unknown
- 2001-10-11 JP JP2002534309A patent/JP2004515475A/ja active Pending
- 2001-10-11 BR BR0114632-7A patent/BR0114632A/pt not_active IP Right Cessation
- 2001-10-11 US US10/399,098 patent/US20040029875A1/en not_active Abandoned
- 2001-10-11 EA EA200300458A patent/EA200300458A1/ru unknown
- 2001-10-11 CZ CZ20031290A patent/CZ20031290A3/cs unknown
- 2001-10-11 WO PCT/FR2001/003133 patent/WO2002030923A1/fr not_active Application Discontinuation
- 2001-10-11 EP EP01978526A patent/EP1324998A1/fr not_active Withdrawn
- 2001-10-11 MX MXPA03002956A patent/MXPA03002956A/es not_active Application Discontinuation
- 2001-10-11 CN CNA018170587A patent/CN1468233A/zh active Pending
- 2001-10-11 PL PL01360090A patent/PL360090A1/xx not_active Application Discontinuation
- 2001-10-11 SK SK571-2003A patent/SK5712003A3/sk unknown
- 2001-10-11 KR KR10-2003-7005208A patent/KR20030036929A/ko not_active Application Discontinuation
- 2001-10-12 AR ARP010104790A patent/AR031726A1/es not_active Application Discontinuation
-
2003
- 2003-04-10 NO NO20031643A patent/NO20031643D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002030923A1 (fr) | 2002-04-18 |
CZ20031290A3 (cs) | 2003-08-13 |
CA2424802A1 (fr) | 2002-04-18 |
US20040029875A1 (en) | 2004-02-12 |
FR2815346A1 (fr) | 2002-04-19 |
FR2815346B1 (fr) | 2004-02-20 |
CN1468233A (zh) | 2004-01-14 |
JP2004515475A (ja) | 2004-05-27 |
MXPA03002956A (es) | 2004-12-13 |
HUP0302408A2 (hu) | 2003-12-29 |
NO20031643L (no) | 2003-04-10 |
AU2002210632A1 (en) | 2002-04-22 |
SK5712003A3 (en) | 2003-11-04 |
AR031726A1 (es) | 2003-10-01 |
KR20030036929A (ko) | 2003-05-09 |
NO20031643D0 (no) | 2003-04-10 |
EP1324998A1 (fr) | 2003-07-09 |
EA200300458A1 (ru) | 2003-08-28 |
PL360090A1 (en) | 2004-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9916282A (pt) | Composto, uso de um um composto e método de tratamento | |
BR0317703A (pt) | Composto, formulação farmacêutica, uso de um composto, processo para a preparação de compostos, e, intermediários | |
EP1423370A4 (en) | COMPOUNDS BINDING TO THE NUCLEAR FXR-NR1H4 RECEPTOR | |
BG101402A (en) | Apoliprotein-b synthesis inhibitors | |
BR0114632A (pt) | Compostos aminotriazolonas, o respectivo processo de preparo e as composições farmacêuticas que os contêm | |
IL70528A0 (en) | Pharmaceutical compositions comprising derivatives of naphthaleneor azanaphthalenecarboxamide,novel derivatives of such compounds and processes for their preparation | |
IL82084A0 (en) | 1,4-diazepines,their preparation and pharmaceutical compositions containing them | |
SE8702120D0 (sv) | 1-(hydroxystyryl)-5h-2,3-benzodiazepine derivatives, process for the preparation thereof and pharmaceutical compositions containing the same | |
BR9603179A (pt) | Guanididas de ácido cinâmico substituìdas, processo para sua preparação, sua aplicação como medicamento ou diagnóstico, bem como medicamento que as contém | |
PT91607A (pt) | Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them | |
ATE62908T1 (de) | Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung. | |
DE3360409D1 (en) | Benzodioxine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
PT1257552E (pt) | Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose | |
KR880007070A (ko) | 백내장 치료용 약학 조성물 | |
GR3022761T3 (en) | Novel benzopyran derivatives and processes for the preparation thereof | |
GR3005059T3 (pt) | ||
BR0116721A (pt) | Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina | |
ATE118346T1 (de) | Verwendung von bis(4-hydroxyphenylthio)methan- derivaten zur behandlung von diabetes mellitus. | |
ES2183500T3 (es) | Nuevos compuestos y composiciones farmaceuticas que los contienen. | |
HUT54688A (en) | Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components | |
JPS5692863A (en) | Novel aminopropanol derivative* its manufacture and heart disease remedy containing it | |
ATE49003T1 (de) | Pregnane derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen, die sie enthalten. | |
AR033156A1 (es) | Derivados de (2-azabiciclo[2.2.1]hept-7-il)metilo y de (2-azabiciclo[2.2.1]hept-5-en-7-il)metilo en calidad de ligandos nicotinicos del receptor para acetilcolina, un procedimiento para su preparacion, las composiciones farmaceuticas que los contienen y el empleo de dichos compuestos para preparar u | |
ZA9010151B (en) | Imidazolyl propyl guanidine derivative,a process for its preparation and a pharmaceutical composition containing this compound | |
JPS5610191A (en) | Clavulanic acid derivative* its manufacture and composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS. |